Evidence map›Paper›PMID 40354396›Full record

ArticlePloS one2025

Construction and application of SARS-CoV-2 protein ontology (CoVPO).

Aaron Nkhata, Xiaona Shi, Yongjuan Zhang, Heng Chen

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Aaron NkhataInstitute of Big Data and Information Technology, Wenzhou University, Wenzhou, China.
Xiaona ShiInstitute of Big Data and Information Technology, Wenzhou University, Wenzhou, China.
Yongjuan ZhangShanghai Institute of Nutrition and Health, Chinese Academy of Sciences, Shanghai, China.ORCID 0000-0002-7776-547X
Heng ChenInstitute of Big Data and Information Technology, Wenzhou University, Wenzhou, China.ORCID 0009-0001-4932-8715

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The emergence of the SARS-CoV-2 virus and the resulting COVID-19 pandemic brought forth an urgent need for an in-depth molecular understanding, organization, and data integration to expedite therapeutic and preventive strategies. An essential approach to achieving this is through the development of a well-structured ontology of SARS-CoV-2 proteins. In response, this paper introduces CoVPO, a SARS-CoV-2 protein ontology that improves upon existing ontologies on protein function annotation and viral-to-viral protein interactions, highlighting their limited scope in covering all aspects of SARS-CoV-2 proteins. CoVPO extends classes from other relevant ontologies. Terms, annotations, and synonyms are added with proper definitions, clear origins, and an interaction map of viral-to-viral protein interactions is captured. We demonstrate CoVPO's application in an information retrieval system, expanding user queries by adding related terms or concepts. This approach helps overcome issues like term mismatch and improves the retrieval of relevant documents. The feasibility and superiority of the domain ontology model are demonstrated through experiments, showing that it outperforms traditional keyword-based searches and provides grounds for further research and discussion in the SARS-CoV-2 protein domain.

Indexed as

Biological OntologiesCOVID-19SARS-CoV-2Viral ProteinsHumansPandemicsViral Proteins

Identifiers

PMID40354396
PMCPMC12068588

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.